Watchlist Price Alert

Crinetics Pharmaceuticals... (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

30.86

-0.09 (-0.29%)

At close: May 14, 2025, 1:15 PM

Crinetics Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	1.04M	4.01M	4.74M	1.08M	71K	1.19M	2.43M	2.04M	589K
Cost of Revenue	n/a	n/a	1.39M	1.26M	57M	1.11M	24.48M	9.23M	5.1M
Gross Profit	-1.75M	4.01M	3.35M	-184K	-56.93M	80K	-22.05M	-7.19M	-4.51M
Operating Income	-338.85M	-222.61M	-167.88M	-107.7M	-74.95M	-53.83M	-28.71M	-9.13M	-6.04M
Interest Income	41.44M	13.44M	4.32M	157K	991K	3.46M	1.75M	26K	37K
Pretax Income	-298.41M	-214.53M	-163.92M	-107.64M	-73.81M	-50.42M	-27.11M	-9.16M	-6.02M
Net Income	-298.41M	-214.53M	-159.95M	-106.72M	-72.86M	-49.53M	-27.11M	-9.16M	-6.02M
Selling & General & Admin	99.74M	58.09M	42.39M	24.52M	18.03M	13.52M	6.66M	1.94M	1.53M
Research & Development	240.16M	168.53M	130.22M	84.25M	57M	41.51M	24.48M	9.23M	5.1M
Other Expenses	n/a	n/a	4.97M	61K	-71K	-1.19M	1.59M	-48K	-1K
Operating Expenses	339.89M	226.62M	172.62M	108.78M	74.95M	53.83M	28.71M	9.13M	6.04M
Interest Expense	n/a	n/a	4.32M	n/a	n/a	n/a	n/a	8K	11K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	339.89M	226.62M	172.62M	108.78M	74.95M	53.83M	28.71M	9.13M	6.04M
Income Tax Expense	n/a	n/a	-3.96M	-922K	-948K	-887K	1.59M	-40K	10K
Shares Outstanding (Basic)	80.78M	58.07M	51.98M	38.44M	30.45M	24.18M	12.14M	13.88M	13.88M
Shares Outstanding (Diluted)	80.78M	58.07M	51.98M	38.44M	30.45M	24.18M	12.14M	13.88M	13.88M
EPS (Basic)	-3.69	-3.69	-3.08	-2.78	-2.39	-2.05	-2.23	-0.66	-0.43
EPS (Diluted)	-3.69	-3.69	-3.08	-2.78	-2.39	-2.05	-2.23	-0.66	-0.43
EBITDA	-338.85M	-221.51M	-166.9M	-106.78M	-72.59M	-49.31M	-28.24M	-9M	-5.95M
EBIT	-338.85M	-222.61M	-167.88M	-107.7M	-74.95M	-53.83M	-27.11M	-9.15M	-6.01M
Depreciation & Amortization	n/a	1.1M	1.39M	1.26M	1.23M	1.11M	471K	128K	92K